Generex Biotechnology Corporation
GNBT · OTC
7/31/2020 | 7/31/2019 | 7/31/2018 | 7/31/2017 | |
|---|---|---|---|---|
| Market Cap | $4,094 | $3,791 | $3,023 | $1,625 |
| - Cash | $15 | $298 | $1,046 | $2,879 |
| + Debt | $11,234 | $8,388 | $14,184 | $13,738 |
| Enterprise Value | $15,313 | $11,881 | $16,161 | $12,484 |
| Revenue | $2,661 | $6,204 | $703 | $0 |
| % Growth | -57.1% | 782.2% | – | – |
| Gross Profit | $2,082 | $2,065 | $703 | $0 |
| % Margin | 78.2% | 33.3% | 100% | – |
| EBITDA | -$26,110 | -$21,072,150 | $36,941 | -$69,268 |
| % Margin | -981.2% | -339,654.2% | 5,252.9% | – |
| Net Income | -$33,335 | -$9,341 | $36,334 | -$70,016 |
| % Margin | -1,252.7% | -150.6% | 5,166.6% | – |
| EPS Diluted | -0.46 | -0.14 | 14.02 | -2.41 |
| % Growth | -228.6% | -101% | 681.7% | – |
| Operating Cash Flow | -$6,121 | -$9,574 | -$2,293 | -$1,170 |
| Capital Expenditures | -$5 | -$316 | -$9 | $0 |
| Free Cash Flow | -$6,126 | -$9,891 | -$2,302 | -$1,170 |